HM
Howard Marks (Oaktree Capital) disclosed increased in BIOMARIN PHARMACEUTICAL INC
Howard Marks (Oaktree Capital) filed a 13F change in BIOMARIN PHARMACEUTICAL INC (09061GAK7) on 2026-05-14, covering period end 2026-03-31.
Action
Increased
Capital
$13,573,999 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.